What are MaxCyte's profit margins?

MaxCyte (MXCT) runs a 80.5% gross margin and a -141.8% operating margin, with a -121.2% net margin.

Where do MaxCyte's ratios come from?

Every ratio is computed from MaxCyte's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

MaxCyte MXCT Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Gross margin	80.5%-0.7pp	81.2%+1.2pp	80%+0.2pp	79.8%-1.1pp	80.9%-0.7pp
Operating margin	-141.8%+15.3pp	-157.1%-1.5pp	-155.6%-6.1pp	-149.6%-13.6pp	-135.9%-3.4pp
Net margin	-121.2%+14.0pp	-135.1%-2.6pp	-132.6%-7.4pp	-125.2%-14.3pp	-110.9%-4.6pp
Returns
Return on equity	-21.3%+2.3pp	-23.6%-0.4pp	-23.2%-1.5pp	-21.7%-2.1pp	-19.6%-0.9pp
Return on invested capital	-25%+3.3pp	-28.4%-0.2pp	-28.2%-1.2pp	-27%-2.5pp	-24.5%+1.0pp
Efficiency
Asset turnover	0.2×0.0×	0.1×0.0×	0.1×0.0×	0.2×0.0×	0.2×0.0×
Liquidity
Current ratio	12×+3.7×	8.3×+0.6×	7.7×-4.7×	12.4×+0.2×	12.2×+1.3×
Leverage
Debt-to-equity	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.1×0.0×
Per Share
Book value per share	$1.57-2.5%	$1.61-4.7%	$1.69-5.7%	$1.79-4.8%	$1.88-4.3%
Valuation
Market capitalization	$130.15M-46.8%	$165.34M-1.8%	$168.44M-28.5%	$235.5M-18.6%	$289.46M-34.0%
Price / sales	4×-2.8×	5×+0.1×	4.9×-1.7×	6.6×-1.1×	7.7×-3.7×
Price / book	0.8×-0.5×	1×0.0×	0.9×-0.3×	1.2×-0.2×	1.5×-0.7×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about MaxCyte.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are MaxCyte's profit margins?: MaxCyte (MXCT) runs a 80.5% gross margin and a -141.8% operating margin, with a -121.2% net margin.
Where do MaxCyte's ratios come from?: Every ratio is computed from MaxCyte's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.